Relatively subtle cognitive disturbances may be present from the initial stages of Parkinson's
disease (PD) that progress in many patients to a more severe cognitive impairment and …

Background and aims (1) To establish the prevalence of mild cognitive impairment (MCI) in
newly diagnosed drug-naive patients with Parkinson's disease adopting recently proposed …

Parkinson's disease (PD) has for decades been considered a pure motor disorder and its
cardinal motor symptoms have been attributed to the loss of dopaminergic (DAergic) …

Little is known about the relationship between cognitive dysfunctions and the non-motor
complex in subjects with newly diagnosed untreated Parkinson's disease (PD). The aim of …

BACKGROUNDS: Worsening of verbal fluency is reported after subthalamic nucleus deep
brain stimulation in Parkinson's disease. It is postulated that these changes could reflect …

Durante los últimos años hemos sido testigos de una utilización preferente de agonistas
dopaminérgicos (AD) como tratamiento de la enfermedad de Parkinson (EP), con la …

Objetivos. Analizar los déficits atencionales en pacientes en estadios intermedios de la EP
en una prueba de atención sostenida compleja y evaluar los efectos del tratamiento con …

Parkinson's disease with dementia (PDD) is now recognised as a major clinical
consequence of idiopathic Parkinson's disease (PD). Indeed the cumulative prevalence of …

Die in dieser Schrift vorgestellten Studien belegen, dass der neuropsychologische und
psychiatrische Status von Patienten mit IPS nicht zuletzt von Nebenwirkungen der …

The spatiotemporal progression of dopamine depletion in Parkinson's disease (PD)
provides a special model for assessing dopaminergic effects on neural systems with …